DAEWON PHARMACEUTICAL CO.,LTD (대원제약(주))
KOSPI Stock Code: 003220 | DART Corp Code: 00111999
English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
| English name (as registered with DART) | DAEWON PHARMACEUTICAL CO.,LTD |
|---|---|
| Korean legal name | 대원제약(주) |
| Alternate names | 대원제약 |
| Market | KOSPI |
| Stock Code | 003220 |
| DART Corp Code | 00111999 |
| CEO | 백승열, BAEK JONATHAN IN |
| Business Registration No. | 2078136336 |
| Corporate Registration No. | 1101110103955 |
| Established Date | 1961-08-09 |
| Fiscal Month | 12 |
| KSIC Industry Code | 212 |
| Address (KO) | 서울특별시 성동구 천호대로 386 대원제약 |
| Homepage | https://www.daewonpharm.com/ |
| source_url | https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318001398 |
| verified_at | 2026-11-01T02:15:22.625Z |
Annual Financial Summary (KRW)
Fiscal Year: 2025 | Basis: CFS (Consolidated) | Currency: KRW | Filing Source: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318001398
| Account | FY2025 (Current) | FY2024 (Prior) |
|---|---|---|
| Revenue (매출액) | KRW 605,434,719,615 | KRW 598,162,352,613 |
| Operating Income (영업이익) | KRW 3,483,326,321 | KRW 28,220,453,539 |
| Net Income (당기순이익) | KRW -4,012,533,918 | KRW 9,044,729,468 |
| Total Assets (자산총계) | KRW 613,651,220,679 | KRW 583,388,833,683 |
| Total Liabilities (부채총계) | KRW 339,072,737,426 | KRW 298,810,595,744 |
| Total Equity (자본총계) | KRW 274,578,483,253 | KRW 284,578,237,939 |
Recent DART Filings (Last 90 Days, up to 20)
| Filed Date | Receipt No. | English Title | Korean Title | Filer |
|---|---|---|---|---|
2026-10-29 | 20261029800655 | Material Business Matters Related to Investment Decisions (미란성 위식도역류질환 환자를 대상으로 DW4421(성분명: 파도프라잔) 투여 후 유효성 및 안전성을 평가하기 위한 제3상 임상시험에 대한 Topline 결과 발표) | 투자판단관련주요경영사항 (미란성 위식도역류질환 환자를 대상으로 DW4421(성분명: 파도프라잔) 투여 후 유효성 및 안전성을 평가하기 위한 제3상 임상시험에 대한 Topline 결과 발표) | 대원제약 |
2026-09-15 | 20260915800538 | Organization of Investor Relations Event | 기업설명회(IR)개최(안내공시) | 대원제약 |
2026-08-28 | 20260828800139 | Implementation and Operation of Compliance Program of the Fair Trade Commission | 공정거래자율준수프로그램운영현황(안내공시) | 대원제약 |
2026-08-07 | 20260807000516 | Semi-annual Report (2026.06) | 반기보고서 (2026.06) | 대원제약 |
Source & Disclaimer
source_url: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318001398 | verified_at: 2026-11-01T02:15:22.625Z
Data from Korea's Financial Supervisory Service (DART) and National Tax Service. FSS does not guarantee accuracy or completeness. Figures in KRW as filed. Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.